November 21, 2024
Jia Xue, Henry Li, Sheng Guo
Discovery and validation of biomarkers from baseline and pharmcodynamic in vitro data is vital in oncology drug development. This process, however, is complex and labor intensive, with few robust tools readily available for automated computation discovery.
We’re developing an automated biomarker discovery platform for in vitro preclinical pharmacology studies. A variety of machine learning algorithms and statistical methods will be combined with an integrated suite of software facilities for data manipulation, calculation, and graphical display.
Your privacy is important to us.
We'll never share your information.
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy
2023-05-22
2021-10-26
landing_page
PDX/Databases